These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 28193

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL, Sapru RP.
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract] [Full Text] [Related]

  • 25. An investigation into the cardiac and pulmonary beta-adrenoceptor blocking activity of ICI 66,082 in man.
    Marlin GE, Kumana CR, Kaye CM, Smith DM, Turner P.
    Br J Clin Pharmacol; 1975 Apr; 2(2):151-7. PubMed ID: 1234497
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF, Richer C, Chauvin M, Idrissi N, Berdeaux A.
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].
    Boudot JP, Cavero I, Fénard S, Lefèvre-Borg F, Manoury P, Roach AG.
    Br J Pharmacol; 1979 Jul; 66(3):445P. PubMed ID: 43176
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG, Brown HC, Carruthers SG, Shanks RG.
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Investigations with beta-adrenoceptor blocking drugs in healthy volunteers.
    Aellig WH.
    Acta Med Scand Suppl; 1977 May; 606():71-5. PubMed ID: 19932
    [No Abstract] [Full Text] [Related]

  • 38. Beta-adrenoceptor blocking agents. 1. Cardioselective 1-aryloxy-3-(aryloxyalkylamino)propan-2-ols.
    Augstein J, Cox DA, Ham AL, Leeming PR, Snarey M.
    J Med Chem; 1973 Nov; 16(11):1245-51. PubMed ID: 4147835
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
    Regårdh CG.
    Acta Pharmacol Toxicol (Copenh); 1975 Nov; 37(1):1-39. PubMed ID: 237402
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.